Menda Y - Search Results

1

A comparison between diagnostic I-123 and posttherapy I-131 scans in the detection of remnant and locoregional thyroid disease.

Thomas DL, Menda Y, Bushnell D. Thomas DL, et al. Among authors: menda y. Clin Nucl Med. 2009 Nov;34(11):745-8. doi: 10.1097/RLU.0b013e3181b7dbb1. Clin Nucl Med. 2009. PMID: 19851166

2

Chemokine Receptor CXCR4 Radioligand Targeted Therapy Using 177Lutetium-pentixather for Pulmonary Neuroendocrine Cancers.

Fath MA, Liu D, Ewald JT, Robles-Planells C, Tomanek-Chalkley AM, Graves SA, Howe JR, O'Dorisio TM, Rastogi P, Bellizzi AM, O'Dorisio MS, Menda Y, Spitz DR. Fath MA, et al. Among authors: menda y. Radiat Res. 2024 Jan 1;201(1):35-47. doi: 10.1667/RADE-23-00064.1. Radiat Res. 2024. PMID: 37989124 Free PMC article.

3

Thallium-201, technetium-99m-tetrofosmin and iodine-131 in detecting differentiated thyroid carcinoma metastases.

Unal S, Menda Y, Adalet I, Boztepe H, Ozbey N, Alagöl F, Cantez S. Unal S, et al. Among authors: menda y. J Nucl Med. 1998 Nov;39(11):1897-902. J Nucl Med. 1998. PMID: 9829579 Free article.

4

Efficacy and safety of repeated samarium-153 lexidronam treatment in a patient with prostate cancer and metastatic bone pain.

Menda Y, Bushnell DL, Williams RD, Miller S, Thomas MO. Menda Y, et al. Clin Nucl Med. 2000 Sep;25(9):698-700. doi: 10.1097/00003072-200009000-00009. Clin Nucl Med. 2000. PMID: 10983757 Clinical Trial.

5

Evaluation of various corrections to the standardized uptake value for diagnosis of pulmonary malignancy.

Menda Y, Bushnell DL, Madsen MT, McLaughlin K, Kahn D, Kernstine KH. Menda Y, et al. Nucl Med Commun. 2001 Oct;22(10):1077-81. doi: 10.1097/00006231-200110000-00004. Nucl Med Commun. 2001. PMID: 11567179

6

Can FDG-PET reduce the need for mediastinoscopy in potentially resectable nonsmall cell lung cancer?

Kernstine KH, Mclaughlin KA, Menda Y, Rossi NP, Kahn DJ, Bushnell DL, Graham MM, Brown CK, Madsen MT. Kernstine KH, et al. Among authors: menda y. Ann Thorac Surg. 2002 Feb;73(2):394-401; discussion 401-2. doi: 10.1016/s0003-4975(01)03432-4. Ann Thorac Surg. 2002. PMID: 11845848

7

Somatostatin receptor imaging of non-small cell lung cancer with 99mTc depreotide.

Menda Y, Kahn D. Menda Y, et al. Semin Nucl Med. 2002 Apr;32(2):92-6. doi: 10.1053/snuc.2002.31564. Semin Nucl Med. 2002. PMID: 11965604 Review.

8

FDG positron emission tomographic imaging of pseudo-pseudo tumor.

Reddy MP, Menda Y, Floresca J, Juweid M, Graham MM. Reddy MP, et al. Among authors: menda y. Clin Nucl Med. 2002 Jun;27(6):445-6. doi: 10.1097/00003072-200206000-00016. Clin Nucl Med. 2002. PMID: 12045443 No abstract available.

9

111In-pentetreotide versus bone scintigraphy in the detection of bony metastases of neuroblastoma.

Juweid ME, Menda Y, O'Dorisio MS, Bushnell D, Blake M, Madsen M, Johnson J, Graham MM. Juweid ME, et al. Among authors: menda y. Nucl Med Commun. 2002 Oct;23(10):983-9. doi: 10.1097/00006231-200210000-00008. Nucl Med Commun. 2002. PMID: 12352597

10

Assessment of hepatic toxicity from treatment with 90Y-SMT 487 (OctreoTher(TM)) in patients with diffuse somatostatin receptor positive liver metastases.

Bushnell D, Menda Y, Madsen M, O'Dorisio T, Carlisle T, Zehr P, Ponto L, Karwal M, Parker S, Ponto J, Connolly M, Bouterfa H. Bushnell D, et al. Among authors: menda y. Cancer Biother Radiopharm. 2003 Aug;18(4):581-8. doi: 10.1089/108497803322287664. Cancer Biother Radiopharm. 2003. PMID: 14503953 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

102 results

Search Page

Filters